Results

Total Results: 2,486 records

Showing results for "evaluating".

101. Musculoskeletal-Complaints-Tests-Children Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_surveillance.pdf
     January 08, 2013 - CER #50: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating … 5 1 Antinuclear Antibody, Rheumatoid Factor, and Cyclic- Citrullinated Peptide Tests for Evaluating … Review (CER) #50, Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating … Rockville, MD: Mar for Evaluating Musculoskeletal Complaints in Children March 2012. … Antinuclear Antibody (ANA), Rheumatoid Factor (RF), and Cyclic-Citrullinated Peptide (CCP) Tests for Evaluating

102. Supplemental Project To Assess the Transparency of Reporting for Trials Evaluating Treatment for Infertility | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/transparency-infertility

103. Disposition of Comments Report for Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Artery Stenting (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_disposition-comments.pdf
     February 26, 2013 - We have reported QCA data if available in individual studies evaluating FFR. … We have reported QCA data if available in individual studies evaluating FFR. … Studies evaluating FFR addressed KQ1 and studies evaluating IVUS addressed KQ2. … In evaluating the clinical evidence, we found three studies that were omitted from consideration as … These studies in Exhibit III demonstrate that OCT is at least as effective as IVUS in evaluating stent

104. Supplemental Project To Assess the Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/transparency-omega-3/research
     June 01, 2017 - These studies should be taken in to account when evaluating the state of the literature and calling for

105. mmeta: Exact Bayesian Inference for Multivariate Meta-analysis of Binary Outcomes | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/mmeta/abstract
     February 11, 2014 - We provide an empirical Bayes method for evaluating overall and study-specific treatment effects in multivariate

106. Methods Guide for Medical Test Reviews Chapter 10 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-decision-models_methods.pdf
     July 01, 2012 - In most cases of evaluating medical testing, some type of formal modeling will be useful. … There are several considerations when evaluating previous modeling studies. … We are explicitly not evaluating patient management strategies where PET is the only test (i.e., PET … Evaluating new screening tests for breast cancer. BMJ 2006; 332(7543):678-679. 20. … Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S.

107. Methods Guide for Medical Test Reviews Chapter 9 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-performance_methods.pdf
     July 01, 2012 - McMaster Evidence-based Practice Center, Hamilton, Ontario, CA Abstract The classical paradigm for evaluating … Introduction In the classical paradigm for evaluating the “accuracy” or performance of a medical test … The first two change the framing of the problem, and forgo the classical paradigm for evaluating test … Random effects models in latent class analysis for evaluating accuracy of diagnostic tests. … Diagnosing diagnostic tests: evaluating the assumptions underlying the estimation of sensitivity and

108. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-options-summarizing.ppt
     June 01, 2012 - For example, when evaluating a test that predicts short-term mortality after a procedure, the true status … This option follows a well-known paradigm in systematic reviews for evaluating prognostic tests (more … Random effects models in latent class analysis for evaluating accuracy of diagnostic tests. … Diagnosing diagnostic tests: evaluating the assumptions underlying the estimation of sensitivity and … Random effects models in latent class analysis for evaluating accuracy of diagnostic tests.

109. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-options-summarizing.ppt
     June 01, 2012 - For example, when evaluating a test that predicts short-term mortality after a procedure, the true status … This option follows a well-known paradigm in systematic reviews for evaluating prognostic tests (more … Random effects models in latent class analysis for evaluating accuracy of diagnostic tests. … Diagnosing diagnostic tests: evaluating the assumptions underlying the estimation of sensitivity and … Random effects models in latent class analysis for evaluating accuracy of diagnostic tests.

110. Nonpharmacologic Interventions for Agitation and Aggression in Dementia | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/dementia-agitation-aggression/research
     March 21, 2016 - Eligible studies included randomized controlled trials evaluating nonpharmacologic interventions to manage

111. Topic 0562 Treatments for Biploar Disorder NSD FINAL SJ (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0663-131114.pdf
     April 10, 2013 -  There are a number of recently published relevant clinical trials evaluating interventions for the

112. Systematic Review Data Repository Plus (SRDR ) | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/srdrplus/overview
     April 02, 2019 - SRDR+ has the flexibility to meet the needs of various types of systematic reviews, such as those evaluating

113. Disposition of Comments Report for Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal Complaints in Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_disposition-comments.pdf
     March 07, 2012 - Comments Report for Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating … Review Title: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating … Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal … With these changes I believe this report will provide very useful information for generalists evaluating

114. Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal Complaints in Children | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/musculoskeletal-complaints-tests-children/

115. Wireless Motility Capsule Versus Other Diagnostic Technologies for Evaluating Gastroparesis and Constipation: Future Research Needs | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/wireless-motility-capsule-future/research

116. Community Forum Deliberative Methods Demonstration: Evaluating Effectiveness and Eliciting Public Views on Use of Evidence | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/deliberative-methods/research-2013-1
     November 01, 2013 - Community Forum Deliberative Methods Demonstration: Evaluating Effectiveness and Eliciting Public Views … Expand the evidence base on public deliberation by evaluating whether public deliberation is an effective

117. 13-MDM347013 30..38 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/whitepaper4-bossuyt02262010-2.pdf
     January 01, 2009 - control strategy and compare the aggregated outcomes in both groups.1 Various randomized designs for evaluating … If such additional pathways exist, evaluating the management effects alone can never be sufficient for … Furthermore, evaluating test accuracy in isolation can never be decisive, even if the benefits of treatment … For evaluating some of the emotional, social, cognitive, and behavioral effects discussed earlier, more … Randomised controlled trial evaluating cardiovascular screening and intervention in general practice

118. 13-MDM347013 30..38 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/outcomes-testing-evaluation_research.pdf
     January 01, 2009 - control strategy and compare the aggregated outcomes in both groups.1 Various randomized designs for evaluating … If such additional pathways exist, evaluating the management effects alone can never be sufficient for … Furthermore, evaluating test accuracy in isolation can never be decisive, even if the benefits of treatment … For evaluating some of the emotional, social, cognitive, and behavioral effects discussed earlier, more … Randomised controlled trial evaluating cardiovascular screening and intervention in general practice

119. Transitional Care Interventions To Prevent Readmissions for People With Heart Failure (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-transition-care_policymaker.pdf
     August 01, 2016 - This is a summary of a systematic review evaluating the evidence regarding the efficacy, comparative … Summary of Evidence From the Systematic Review Within 30 days after discharge üü Evaluating 30-day readmission

120. Assessing the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-bias-individual-studies_methods.pdf
     March 01, 2012 - In preparation for evaluating the overall strength of evidence, reviewers should separate criteria for … Similarly, evaluating the potential for selective outcome reporting bias is complex when considering … Evaluating non-randomised intervention studies. Health Technol Assess 2003;7(27):iii-x, 1-173. … applicable to studies evaluating interventions (both randomized and nonrandomized studies). … Evaluating non-randomised intervention studies. Health Technol Assess 2003;7(27):iii-x, 1-173.